ARQ 197 in Subjects With Metastatic Solid Tumors

NCT00302172 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Tumor

Interventions

DRUG: ARQ 197

Sponsor

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)